Sonneveld, M. J. Et Al. 2012. Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-alpha 2b: relation to response and HBV genotype. ANTIVIRAL THERAPY , vol.17, no.1 , 9-17.

Sonneveld, M. J., Rijckborst, V., Cakaloglu, Y., Simon, K., Heathcote, E. J., Tabak, F., ... Mach, T.(2012). Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-alpha 2b: relation to response and HBV genotype. ANTIVIRAL THERAPY , vol.17, no.1, 9-17.

Sonneveld, Milan Et Al. "Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-alpha 2b: relation to response and HBV genotype," ANTIVIRAL THERAPY , vol.17, no.1, 9-17, 2012

Sonneveld, Milan J. Et Al. "Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-alpha 2b: relation to response and HBV genotype." ANTIVIRAL THERAPY , vol.17, no.1, pp.9-17, 2012

Sonneveld, M. J. Et Al. (2012) . "Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-alpha 2b: relation to response and HBV genotype." ANTIVIRAL THERAPY , vol.17, no.1, pp.9-17.

@article{article, author={Milan J. Sonneveld Et Al. }, title={Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-alpha 2b: relation to response and HBV genotype}, journal={ANTIVIRAL THERAPY}, year=2012, pages={9-17} }